Skip to main content
SpringerLink
Log in

Anxiolytika

  • Chapter
  • First Online:
Kompendium der Psychiatrischen Pharmakotherapie

  • 1655 Accesses

Zusammenfassung

Indikationen, Wirkungsweise, Nebenwirkungen und Risiken, Kontraindikationen und Interaktionen werden für die Anxiolytika im allgemeinen Teil und dann für jedes Arzneimittel spezifisch im Präparateteil beschrieben. Außerdem werden Substanzen besprochen, deren primäre Indikation außerhalb der Angststörungen liegt, die aber auch bei diesen wirksam sind.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

Literatur

  • AlDawsari A, Bushell TJ, Abutheraa N et al (2022) Use of sedative-hypnotic medications and risk of dementia: a systematic review and meta-analysis. Br J Clin Pharmacol 88(4):1567–1589. https://doi.org/10.1111/bcp.15113

    Article  PubMed  Google Scholar 

  • Appiani FJ, Duarte JM, Sauré M et al (2023) Catatonia and delirium: assessment of comorbidity, prevalence, and therapeutic response in medically ill inpatients from a University Hospital. J Clin Psychopharmacol 43(1):55–59

    Article  PubMed  Google Scholar 

  • Bandelow B (2020) Current and novel psychopharmacological drugs for anxiety disorders. Adv Exp Med Biol 1191:347–365

    Article  CAS  PubMed  Google Scholar 

  • Bandelow B, Aden I, Alpers GW et al (2021) Deutsche S3-Leitlinie Behandlung von Angststörungen, Version 2. https://register.awmf.org/de/leitlinien/detail/051-028. Zugegriffen: 25. Mai 2023

  • Bedse G, Bluett RJ, Patrick TA et al (2018) Therapeutic endocannabinoid augmentation for mood and anxiety disorders: comparative profiling of FAAH, MAGL and dual inhibitors. Transl Psychiatry 8(1):92

    Article  PubMed  PubMed Central  Google Scholar 

  • Bonnet U, McAnally HB (2022) How prevalent and severe is addiction on GABAmimetic drugs in an elderly German general hospital population? Focus on gabapentinoids, benzodiazepines, and z-hypnotic drugs. Hum Psychopharmacol 37(3):e2822

    Article  CAS  PubMed  Google Scholar 

  • Buth S, Holzbach R, Martens MS et al (2019) Problematic medication with benzodiazepines, „Z-drugs“, and opioid analgesics – An analysis of national health insurance prescription data from 2006–2016. Dtsch Ärztebl Int 116:607–614

    PubMed  PubMed Central  Google Scholar 

  • Chen TY, Winkelman JW, Mao WC et al (2018) The use of benzodiazepine receptor agonists and the risk of hospitalization for pneumonia: a nationwide population-based nested case-control study. Chest 153(1):161–171

    Article  PubMed  Google Scholar 

  • Chincholkar M (2020) Gabapentinoids: pharmacokinetics, pharmacodynamics and considerations for clinical practice. Br J Pain 14(2):104–114

    Article  PubMed  PubMed Central  Google Scholar 

  • Crapanzano C, Damiani S, Guiot C (2021) Quetiapine in the anxiety dimension of mood disorders: a systematic review of the literature to support clinical practice. J Clin Psychopharmacol 41(4):436–449

    Article  PubMed  Google Scholar 

  • Dold M, Bartova L, Volz H-P et al (2023) Efficacy of Silexan in patients with anxiety disorders: a meta-analysis of randomized, placebo-controlled trials. Eur Arch Psychiatry Clin Neurosci. https://doi.org/10.1007/s00406-022-01547-w

    Article  PubMed  PubMed Central  Google Scholar 

  • Ferreira P, Perreira AR, Barreto B et al (2022) Is there a link between the use of benzodiazepines and related drugs and dementia? A systematic review of reviews. Eur Geriatr Med 13(1):19–32

    Article  PubMed  Google Scholar 

  • Fond G, Berna F, Boyer L et al (2018) Benzodiazepine long-term administration is associated with impaired attention/working memory in schizophrenia: results from the national multicentre FACE-SZ data set. Eur Arch Psychiatry Clin Neurosci 268(1):17–26

    Article  PubMed  Google Scholar 

  • Garakani A, Murrough JW, Freire RC et al (2020) Pharmacotherapy of anxiety disorders: current and emerging treatment options. Front Psychiatry 11:595584

    Article  PubMed  PubMed Central  Google Scholar 

  • Goldschen-Ohm MP (2022) Benzodiazepine modulation of GABAA receptors: a mechanistic perspective. Biomolecules 12(12):1784

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Gottschalk MG, Domschke K (2018) Oxytocin and anxiety disorders. Curr Top Behav Neurosci 35:467–498

    Article  CAS  PubMed  Google Scholar 

  • Hägg S, Jönsson AK, Ahlner J (2020) Current evidence on abuse and misuse of gabapentinoids. Drug Saf 43(12):1235–1254

    Article  PubMed  PubMed Central  Google Scholar 

  • Hammad AM, Naser A, Amawi H et al (2023) Effect of amoxicillin/clavulanic acid in attenuating pregabalin-induced condition place preference. Behav Brain Res 439:114244

    Article  CAS  PubMed  Google Scholar 

  • Santos LS, Stackmann M, Munoz Zamora A et al (2021) Propranolol decreases fear expression by modulating fear memory traces. Biol Psychiatry 89(12):115–1161

    Google Scholar 

  • Lüddens H (2012) Anxiolytika und Hypnotika. In: Gründer G, Benkert O (Hrsg) Handbuch der Psychopharmakotherapie, 2. Aufl. Springer, Berlin, Heidelberg, New York, S 695–712

    Chapter  Google Scholar 

  • McAnally H, Bonnet U, Kaye AD (2020) Gabapentinoid benefit and risk stratification: mechanismus over myth. Pain Ther 9:441–452

    Article  PubMed  PubMed Central  Google Scholar 

  • Molero Y, Larsson H, D’Onofrio BM et al (2019) Associations between gabapentinoids and suicidal behaviour, unintentional overdoses, injuries, road traffic incidents, and violent crime: population based cohort study in Sweden. BMJ 365:l2147

    Article  PubMed  PubMed Central  Google Scholar 

  • Murphy CP, Singewald N (2019) Role of microRNAs in anxiety and anxiety-related disorders. Curr Top Behav Neurosci 42:185–219

    CAS  PubMed  Google Scholar 

  • Peng L, Meeks TW, Blazes CK (2022) Complex persistent benzodiazepine dependence when benzodiazepine deprescribing goes awry. JAMA Psychiatry 79(7):639–640. https://doi.org/10.1001/jamapsychiatry.2022.1150

    Article  PubMed  Google Scholar 

  • Riemer TG, Fuentes LEV, Algharably EAE et al (2021) Do β-blockers cause depression?: Systematic review and meta-analysis of psychiatric adverse events during β-blocker therapy. Hypertension 77(5):1539–1548

    Article  CAS  PubMed  Google Scholar 

  • Sanchez-Vidana DI, Po KK, Fung TK et al (2019) Lavender essential oil ameliorates depression-like behavior and increases neurogenesis and dendritic complexity in rats. Neurosci Lett 701:182–190

    Article  Google Scholar 

  • Shi Y, Cui M, Ochs K et al (2022) Long-term diazepam treatment enhances microglial spine engulfment and impairs cognitive performance via the mitochondrial 18 kDa translocator protein (TSPO). Nat Neurosci 25(3):317–329

    Article  CAS  PubMed  Google Scholar 

  • Silberman E, Balon R, Starcevic V et al (2021) Benzodiazepines: it’s time to return to the evidence. Br J Psychiatry 218(3):125–127

    Article  PubMed  Google Scholar 

  • Singewald N, Sartori SB, Reif A et al (2023) Alleviating anxiety and taming trauma: novel pharmacotherapeutics for anxiety disorders and posttraumatic stress disorder. Neuropharmacology 226:109418

    Article  CAS  PubMed  Google Scholar 

  • Skelley JW, Deas CM, Curren Z et al (2020) Use of cannabidiol in anxiety and anxiety-related disorders. J Am Pharm Assoc 60(1):253–261. https://doi.org/10.1016/j.japh.2019.11.008

    Article  Google Scholar 

  • Slee A, Nazareth I, Bondaronek P, Liu Y et al (2019) Pharmacological treatments for generalised anxiety disorder: a systematic review and network meta-analysis. Lancet 393(10173):768–777

    Article  CAS  PubMed  Google Scholar 

  • Vloet TD, Romanos M (2021) Angststörungen – von der ICD-10 zur ICD-11. Z Kinder Jugendpsychiatr Psychother 49(6):429–435

    Article  PubMed  Google Scholar 

  • Yoon S, Kim YK (2022) Possible oxytocin-related biomarkers in anxiety and mood disorders. Prog Neuropsychopharmacol Biol Psychiatry 116:110531

    Article  CAS  PubMed  Google Scholar 

  • Zhu S, Sridhar A, Teng J et al (2022) Structural and dynamic mechanismus of GABAA receptor modulators with opposing activities. Nat Commun 13(1):4582

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Berlin, Deutschland

    Prof. Dr. med. Ion-George Anghelescu

  2. Mainz, Deutschland

    Prof. Dr. med. Otto Benkert

Authors
  1. Prof. Dr. med. Ion-George Anghelescu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Prof. Dr. med. Otto Benkert
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Otto Benkert .

Editor information

Editors and Affiliations

  1. ehemals Universitäts-Klinikum Mainz, Mainz, Deutschland

    Otto Benkert

  2. ehemals Universitäts-Klinikum München, München, Deutschland

    Hanns Hippius

Rights and permissions

Reprints and permissions

Copyright information

© 2023 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Anghelescu, IG., Benkert, O. (2023). Anxiolytika. In: Benkert, O., Hippius, H. (eds) Kompendium der Psychiatrischen Pharmakotherapie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-67685-1_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-67685-1_4

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-67684-4

  • Online ISBN: 978-3-662-67685-1

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation